The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.
This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.
Dr. Kelly is a Professor of Pediatrics, the Minnesota American Legion and Auxiliary Chair in Children’s Health, and the Co-Director of the Center for Pediatric Obesity Medicine at the University of Minnesota Medical School. He has over 20 years of experience conducting clinical trials for the treatment of pediatric obesity and has published over 100 peer-reviewed papers on related topics. Dr. Kelly’s NIH-funded research program focuses primarily on obesity pharmacotherapy but extends to all types of weight management interventions. His work also seeks to identify and characterize predictors of treatment response to advance the discipline of precision obesity medicine and improve care delivery for children and adolescents with obesity. Dr. Kelly is actively involved in numerous initiatives related to pediatric obesity treatment in the United States and internationally, has held various leadership positions in The Obesity Society and American Heart Association, and is a Fellow of both organizations.